InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Sunday, 08/09/2020 11:27:20 AM

Sunday, August 09, 2020 11:27:20 AM

Post# of 44690
Why doesn't Relief seek the sickest patients in their clinical trials.?.
Compare Exclusion criteria with another company's Inclusion criteria. Obviously a drug that is for sicker patients will work for those not so sick. I wont post the name. The hype is here but it may still be a rush to successful data readouts. JMO. What the Trials state/are trying to prove matters. JMO. Some act like this is a done deal for all COVID issues. I dont think so. These criteria leave alot of open ground...
Disclaimer, I missed the <$.15 boat and watched it sail. But I never say never, this is the play today, Congratulations.

aviptadil NCT04360096 Not yet recruiting (inhaled)
Inclusion Criteria:

Moderate or Severe COVID-19 by FDA definition with no evidence of Respiratory Failure
Capable of using mesh nebulizer to administer medication with assistance if needed

Exclusion Criteria:**

Evidence of Respiratory Failure
Use or impending use of ventilation or high flow nasal oxygen 20L or greater
-------------------------

NCT04311697 recruiting (intravenous)
SOC is defined not to include extracorporeal mechanical oxygenation.

Verses.....


"Inclusion Criteria:

Male and female subjects aged ≥18 years of age
Confirmed coronavirus infection

Positive real-time fluorescence polymerase chain reaction of the patient's respiratory or blood specimens for COVID-19 nucleic acid
Viral gene sequences in respiratory or blood specimens that are highly homologous to COVID-19
Any other diagnostic test accepted by local regulatory authorities

Must be hospitalized and requiring supplemental oxygen, or on non-invasive ventilation or high flow oxygen devices (Score of 4 or 5 on WHO Ordinal Clinical Scale)"!!!
===========================